Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Translink Capital is a venture capital and private equity firm founded in 2007, managing approximately $715 million across 11 funds. They focus on seed to Series B technology startups, primarily Series A, and have made 171 investments with 31 portfolio exits. The firm has a strong cross-border Asia focus, leveraging networks in Asia for portfolio growth, and 69% of its portfolio companies are minority-led.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Translink Capital.